PROMEDICA INTERNATIONAL
and DEVICEPHARM STRATEGIC ALLIANCE FOR THE EXPANSION OF MEDICAL
PRODUCT SERVICES OFFERING
DevicePharm expertise in medical product commercialization's
creative
services is cited by PMI as a key reason for alliance.
Costa Mesa, California -August 14, 2007- Promedica
International (PMI), a CRO with extensive experience in Phase
II-IV clinical research announced today the establishment
of a new strategic alliance with DevicePharm.
DevicePharm, Inc., a provider of integrated marketing solutions
for medical device and pharmaceutical companies, has its corporate
office in Irvine, California. The company's medical commercialization
services include: corporate positioning and brand strategy;
global launch planning; professional writing; graphic design,
animation and illustration; video and film concept and production;
Internet and interactive medical production media planning
and placement; trade show promotion; collateral materials;
clinical guides; direct to consumer advertising; physician
to consumer communications; and public relations. The DevicePharm
team has received dozens of national and international awards
for its work
PMI chose to formalize the alliance with DevicePharm based
on previous experience, which highlighted the firms' cultural
similarities in terms of client orientation and service. "The
PMI-DevicePharm alliance expands both firms' capabilities
for providing an integrated approach to client needs. Because
of the inter-relatedness of clinical programs and medical
product marketing, our combined experience and service provider
relationships in clinical research and medical product commercialization
facilitates comprehensive, efficient global implementation
of services in these areas Over the years we have had various
alliance opportunities - we find DevicePharm's capabilities
and culture to be a good match with PMI's focus on people,
processes and performance", said Ellen Palo, PMI founder.
"The PMI-DevicePharm alliance creates additional value",
stated Clay Wilemon, Chief Executive and Chief Strategy Officer
of DevicePharm. "It is important for our clients, both
those early stage clients and those with extensive Phase IV
clinical needs to have the opportunity to integrate marketing
and clinical planning to achieve their business objectives.""
Shannon Stoddard, Vice President of Clinical Services and
Data Management at PMI, will oversee the integration of clinical
research activities with DevicePharm's marketing solutions.
Ms. Stoddard said, "It is very positive to have an alliance
with this level of medical market focus and experience. DevicePharm's
specialized knowledge in medical marketing essentials enables
us to confidently provide our clients with appropriate medical
product market planning, strategies, and implementation."
About Promedica International
Promedica International (PMI) is a privately held corporation
with headquarters located in Costa Mesa, California. Founded
in 1985, the company provides specialized clinical research
services to the medical device, biotech and pharmaceutical
industries. The company is ISO 9001:2000 certified, servicing
a range of medical specialties and therapeutic areas.
For more information, please visit www.promedica-intl.com.
About DevicePharm, Inc.
DevicePharm is a marketing strategy and integrated marketing
communications firm headquartered in Irvine, California. The
company's mission is to help medical device and pharmaceutical
companies, and providers who use their products, to achieve
their business objectives. The company and its founders have
a legacy dating back to 1990, and a successful track record
with Fortune 500, mid-range and early stage medical device
and pharmaceutical companies.
For more information, please visit www.devicepharm.com
|
